| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 701.69B | 716.14B | 702.08B | 680.09B | 662.20B | 602.70B |
| Gross Profit | 126.73B | 129.22B | 126.23B | 120.15B | 108.87B | 102.25B |
| EBITDA | 61.22B | 61.09B | 63.30B | 61.73B | 55.63B | 52.78B |
| Net Income | 23.93B | 27.33B | 24.73B | 24.50B | 21.57B | 23.38B |
Balance Sheet | ||||||
| Total Assets | 502.60B | 557.24B | 504.46B | 489.72B | 461.36B | 431.77B |
| Cash, Cash Equivalents and Short-Term Investments | 39.17B | 52.11B | 39.37B | 31.28B | 27.84B | 23.41B |
| Total Debt | 111.75B | 124.75B | 106.25B | 97.95B | 114.58B | 104.71B |
| Total Liabilities | 230.01B | 252.80B | 228.49B | 223.77B | 227.84B | 213.87B |
| Stockholders Equity | 256.85B | 286.35B | 260.04B | 253.41B | 224.44B | 211.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 18.55B | 24.87B | 35.72B | 14.04B | 13.37B |
| Operating Cash Flow | 0.00 | 48.75B | 53.19B | 62.44B | 37.87B | 34.66B |
| Investing Cash Flow | 0.00 | -29.94B | -32.40B | -31.41B | -26.84B | -26.02B |
| Financing Cash Flow | 0.00 | -6.34B | -16.80B | -31.43B | -8.59B | -14.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥634.69B | 14.65 | 9.18% | 1.13% | 5.55% | 17.29% | |
71 Outperform | ¥5.12T | 23.62 | 9.46% | 1.32% | 3.47% | 99.65% | |
65 Neutral | ¥414.41B | 14.90 | 10.18% | 2.56% | 5.09% | 10.53% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | ¥458.06B | 18.06 | 9.86% | 2.58% | 2.00% | 12.21% | |
56 Neutral | ¥562.37B | 19.47 | 6.04% | 2.04% | 6.34% | 38.64% | |
53 Neutral | ¥771.41B | 19.10 | 9.77% | 2.41% | 1.49% | -14.54% |